Topics:
Gastrointestinal Cancers • Medical Oncology • Liver and Pancreas Tumors • NCI-CCC Tumor Board Question • Rutgers • NCI-CCC GI Tumor Board Question
What would you recommend for an elderly patient (> 80 year old) with resectable pancreatic cancer?
Upfront surgery vs neoadjuvant therapy? And if neoadjuvant therapy, which regimen?
Patient has a good PS.
Answer from: Medical Oncologist at Academic Institution
This is an excellent question and not just for the elderly population cited, but as a global query. There are no randomized trials that suggest resectable patients have improved survival. On the other hand, even with resection, more than 90% of patients will recur, and adjuvant therapy is recommende...
Sign in or Register to read more